No mediolateral differences in striatal autoreceptor-mediated modulation of dopamine release: in vivo voltammetric data

Neurosci Lett. 1990 Feb 5;109(1-2):123-7. doi: 10.1016/0304-3940(90)90549-o.

Abstract

Medial and lateral neostriatum differ qualitatively in their sources of dopamine (DA) innervation and in their behavioural functions. The present study sought to ascertain whether these differences were reflected in their response to DA autoreceptor drugs. Fast cyclic voltammetry was used to measure stimulated DA release at medial and lateral carbon fibre microelectrodes. Metoclopramide and (+)-3-PPP were used as autoreceptor antagonist and agonist respectively. No differences were observed in the level of DA release evoked by stimulation or in the agonist and antagonist responses at medial or lateral sites. We therefore conclude that differences between medial and lateral striatal DA function are not evident at the autoreceptor level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology
  • Dopamine Antagonists
  • Electrochemistry
  • Male
  • Metoclopramide / pharmacology*
  • Piperidines / pharmacology*
  • Rats
  • Rats, Inbred Strains

Substances

  • Dopamine Agents
  • Dopamine Antagonists
  • Piperidines
  • preclamol
  • Metoclopramide
  • Dopamine